Page last updated: 2024-12-08

1-(5'-phospho-beta-d-ribofuranosyl)barbituric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-oxouridine 5'-phosphate : A pyrimidine ribonucleoside 5'-monophosphate that is the 6-oxo derivative of UMP. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID445132
CHEMBL ID1231399
CHEBI ID41150
SCHEMBL ID1364683
MeSH IDM0091394

Synonyms (15)

Synonym
chebi:41150 ,
CHEMBL1231399
1-(5'-phospho-beta-d-ribofuranosyl)barbituric acid
BMQ ,
5,6-dihydro-6-oxouridine 5'-phosphate
DB03668 ,
5,6-dihydro-6-oxouridine 5'-monophosphate
1X1Z
6-oxouridine 5'-phosphate
[(2r,3s,4r,5r)-3,4-dihydroxy-5-(2,4,6-trioxo-1,3-diazinan-1-yl)oxolan-2-yl]methyl dihydrogen phosphate
6-oxouridine 5'-(dihydrogen phosphate)
SCHEMBL1364683
1-(5-phospho-beta-d-ribofuranosyl)barbituric acid
Q27120419
PD059572
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyrimidine ribonucleoside 5'-monophosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Orotidine 5'-phosphate decarboxylaseMethanothermobacter thermautotrophicusKi0.00000.00000.00000.0000AID977610
Chain B, Orotidine 5'-phosphate decarboxylaseMethanothermobacter thermautotrophicusKi0.00000.00000.00000.0000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID227718Binding energy by using the equation deltaG obsd = -RT ln KD1984Journal of medicinal chemistry, Dec, Volume: 27, Issue:12
Functional group contributions to drug-receptor interactions.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2005Journal of the American Chemical Society, Nov-02, Volume: 127, Issue:43
An unprecedented twist to ODCase catalytic activity.
AID1811Experimentally measured binding affinity data derived from PDB2005Journal of the American Chemical Society, Nov-02, Volume: 127, Issue:43
An unprecedented twist to ODCase catalytic activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (26.67)18.7374
1990's6 (40.00)18.2507
2000's5 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.64 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (13.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]